- You can view the full Monsanto Ratings Report.
- Use our chemicals section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Bayer isn't expecting their deal for Monsanto to be derailed by regulatory issues, despite recent delays.
Bayer shares fell after the drugmaker posted solid full-year earnings but said its crop sciences unit would see modest growth in 2017 as it completes its $66 billion Monsanto takeover.